Published in Can Med Assoc J on June 01, 1981
Fulminant Mycoplasma pneumoniae pneumonia. West J Med (1995) 1.59
Manifestations and complications of Mycoplasma pneumoniae disease: a review. Yale J Biol Med (1984) 1.09
Epidemiology and clinical features of segmental/lobar pattern Mycoplasma pneumoniae pneumonia: A ten-year retrospective clinical study. Exp Ther Med (2015) 0.77
The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med (1975) 3.06
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. Am J Epidemiol (1967) 2.11
Mycoplasma infections of man. N Engl J Med (1965) 2.11
Atypical pneumonias. Med Clin North Am (1980) 1.88
Eaton agent pneumonia-clinical features. JAMA (1961) 1.83
Comparison of antibiotics in the treatment of mycoplasmal pneumonia. Arch Intern Med (1970) 1.58
Radiographic appearance of mycoplasmal pneumonai. Scand J Respir Dis (1978) 1.41
Role of mycoplasmas in human respiratory disease. Med Clin North Am (1967) 1.40
Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966. Am Rev Respir Dis (1968) 1.36
Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung. JAMA (1967) 1.30
Frequency of pleural effusions in mycoplasma and viral pneumonias. N Engl J Med (1970) 1.22
Radiographic study of mycoplasma pneumoniae pneumonia. Am Rev Respir Dis (1973) 1.02
The radiographic patterns of acute mycoplasma pneumonitis. Clin Radiol (1977) 0.99
Roentgenographic appearance of viral and mycoplasmal pneumonias. Am Rev Respir Dis (1967) 0.94
The roentgen features of Eaton agent pneumonia. Am J Roentgenol Radium Ther Nucl Med (1966) 0.84
Letter: Mycoplasma pneumoniae infection. S Afr Med J (1975) 0.81
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82
Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest (1995) 2.47
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
In vitro evaluation of cefoxitin and cefamandole. Antimicrob Agents Chemother (1976) 1.78
Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol (1987) 1.78
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med (1997) 1.71
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest (1996) 1.65
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Mechanism of perennial allergic asthma. Lancet (1983) 1.58
Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Ann Allergy Asthma Immunol (1998) 1.58
Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis (1980) 1.57
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis (1979) 1.57
OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy (2014) 1.54
Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis (1977) 1.53
Methacholine PC20 extrapolation. Chest (1998) 1.50
Right-sided aortic arch presenting as refractory intraoperative and postoperative wheezing. Chest (1991) 1.45
Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J (2009) 1.45
Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest (1983) 1.44
Indirect airway challenges. Eur Respir J (2003) 1.42
Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol (1995) 1.25
Calcitonin from ultimobranchial glands of dogfish and chickens. Science (1967) 1.20
Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis (1987) 1.16
Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold. Thorax (1983) 1.13
Ultimobranchial origin of calcitonin. Hypocalcemic effect of extracts from chicken glands. Can J Physiol Pharmacol (1967) 1.12
Factors in allergen-induced asthma: relevance of the intensity of the airways allergic reaction and non-specific bronchial reactivity. Clin Allergy (1976) 1.11
Increased bronchial reactivity to inhaled histamine in nonsmoking grain workers with normal lung function. Chest (1980) 1.08
Nighttime ventilation improves respiratory failure in secondary kyphoscoliosis. Am Rev Respir Dis (1984) 1.08
Asthma caused by occupational exposure to a furan-based binder system. J Allergy Clin Immunol (1980) 1.08
Nonspecific bronchial hyperreactivity after exposure to Western Red Cedar. Am Rev Respir Dis (1979) 1.08
Miliary tuberculosis presenting with hyponatremia and thrombocytopenia. Can Med Assoc J (1976) 1.07
Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J (1993) 1.06
Determination of histamine PC20. Comparison of linear and logarithmic interpolation. Chest (1983) 1.05
Assessment of endotoxin levels in the home and current asthma and wheeze in school-age children. Indoor Air (2008) 1.05
Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe-positive for Mycobacterium avium complex. Int J Syst Evol Microbiol (2004) 1.05
Bronchial response to inhaled histamine in asymptomatic young smokers. Eur J Respir Dis (1983) 1.02
Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered (1990) 1.01
The beta-agonist controversy. Med Clin North Am (1996) 1.00
In vitro evaluation of a new oral cephalosporin, cefatrizine (BL-s640). Antimicrob Agents Chemother (1975) 0.99
The acute bacterial pneumonias. Semin Roentgenol (1980) 0.99
The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy (2007) 0.98
Cigarette smoking, airway hyperresponsiveness, and asthma. Chest (1988) 0.97
Out-patient management of bronchial asthma. Can Fam Physician (1989) 0.96
Slope of the dose-response curve: usefulness in assessing bronchial responses to inhaled histamine. Thorax (1983) 0.96
Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol (2000) 0.96
Asthma management in the emergency department. Can Respir J (2000) 0.96
Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax (1987) 0.94
Volume adjustment of maximal midexpiratory flow. Importance of changes in total lung capacity. Chest (1980) 0.94
Decrease in non-specific bronchial reactivity in an asthmatic following treatment of hyperthyroidism. Ann Allergy (1978) 0.93
Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med (1999) 0.92
Characteristics of airway tone during exercise in patients with asthma. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.92
Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J (1976) 0.91
Standardization of inhalation provocation tests. Dose vs concentration of histamine. Chest (1982) 0.91
Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model. J Allergy Clin Immunol (1997) 0.91
Occupational asthma caused by cedar urea formaldehyde particle board. Chest (1982) 0.90
Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol (1977) 0.90
Self-injection with olive oil. A cause of lipoid pneumonia. Chest (1995) 0.90
Isocyanate-induced asthma in an automobile spray painter. Can Med Assoc J (1979) 0.89
Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype. Can Med Assoc J (1981) 0.89
Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society. Eur Respir J (1998) 0.89
Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol (1996) 0.89
Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection. Chest (2001) 0.89
Effect of Sch1000 in allergen-induced asthma. Clin Allergy (1978) 0.88
Correlation of bronchial responsiveness to diluent and to histamine. Ann Allergy (1982) 0.87
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ (1995) 0.87
How best to measure airway responsiveness. Am J Respir Crit Care Med (2001) 0.87
Pulmonary function in Pi M and MZ grainworkers. Chest (1986) 0.87
Respiratory health risks in farmers. Ann Intern Med (1981) 0.86
Bronchiolitis obliterans and Mycoplasma pneumonia. Respir Med (1991) 0.85
Bronchial inhalation tests. I. Measurement of nonallergic bronchial responsiveness. Ann Allergy (1985) 0.85
Constrictive bronchiolitis and ulcerative colitis. Can Respir J (1999) 0.85
Increased airways responsiveness in swine farmers. Chest (1991) 0.85
Acquired persistent increase in nonspecific bronchial, reactivity associated with isocyanate exposure. Ann Allergy (1982) 0.85
The effect of helium on nasal resistance and nasal flows. Am Rev Respir Dis (1979) 0.84
Effect of pH on bronchial response to inhaled histamine. Thorax (1982) 0.84
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J (2003) 0.84
The role of thromboxane in allergen-induced asthmatic responses. Eur Respir J (1991) 0.84
Nasal airway inspiratory resistance. Am Rev Respir Dis (1979) 0.83
Is there a negative correlation between malignancy and respiratory atopy? Ann Allergy (1979) 0.83
Letter: Creatinine clearance and age. Lancet (1975) 0.83
Airway responsiveness to inhaled histamine in chronic obstructive airways disease. Chronic bronchitis vs emphysema. Chest (1988) 0.83
Measurement of responsiveness to inhaled histamine: comparison of FEV1 and SGaw. Ann Allergy (1983) 0.83
Ethnicity as a possible factor contributing to the development of chronic airflow limitation and asthma. Clin Invest Med (1990) 0.82
Effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol (1985) (1989) 0.82
Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J Allergy Clin Immunol (1983) 0.82
Occupational obstructive disorders: nonspecific airways obstruction and occupational asthma. Med Clin North Am (1990) 0.82
Eosinophilic bronchitis as a cause of cough. Chest (2000) 0.81
Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen. J Allergy Clin Immunol (1998) 0.81
Localization of emphysema within the lung. An hypothesis based upon ventilation/perfusion relationships. Chest (1982) 0.80
Tolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium. Respir Med (1990) 0.79
Risk factors for reduced pulmonary function in women. A possible relationship between Pi phenotype, number of children, and pulmonary function. Chest (1992) 0.79
Severe acute "occupational asthma" caused by accidental allergen exposure in an allergen challenge laboratory. Ann Allergy (1985) 0.79
Lower prevalence of positive atopic skin tests in lung cancer patients. Chest (1988) 0.79
The effect of atropine on allergen-induced increases in bronchial responsiveness to histamine. Am Rev Respir Dis (1984) 0.79